Back

Clinical impact of inappropriate DOAC dosing in atrial fibrillation: insights from a real-world registry

14 March 2025 (16:10 - 17:10)
Organised by: Logo
Congress Presentation Part of: Arrhythmias in acute cardiac care Epidemiology, Prognosis, Outcome ACVC Premium Access ESC Acute CardioVascular Care 2025 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Mustafa Yildirim

University Hospital Heidelberg, Heidelberg (Germany)

5 More presentations in this session

Presentation thumbnail
Newly diagnosed HFpEF in patients with atrial fibrillation: prevalence and impact on antiarrhythmic and antithrombotic management
Doctor W. Villon (Guayaquil, EC)
Abstract Slides
Presentation thumbnail
Electrical cardioversion of long-standing persistent atrial fibrillation: the importance of antiarrhythmic pretreatment
Doctor S. Andraz (Faro, PT)
Abstract Slides
Presentation thumbnail
Importance of immediate bystander life support on short and long-term survival of patients with out-of-hospital cardiac arrest and myocardial infarction
Associate Professor A. Aleksova (Trieste, IT)
Abstract Slides
Presentation thumbnail
Primary ventricular fibrillation epidemic in the STEMI Code era. Trends and acute-phase mortality over the last 15 years
Doctor C. Garcia-Garcia (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Taming ventricular tachycardia: experience of stellate ganglion ablation across the spectrum of ventricular arrhythmias, a safe and effective intervention beyond the electrical storm
Doctor J. Larre Guerra (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Arrhythmias in acute cardiac care

The Event

Event poster

ESC Acute CardioVascular Care 2025

14 March 2025 16:10 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources